SPX3,647.29-7.75 -0.21%
DIA291.30-1.42 -0.49%
IXIC10,829.50+26.58 0.25%

BRIEF-Quoin Pharmaceuticals Establishes Patient Specific Website For Ongoing Netherton Syndrome Clinical Study

BRIEF-Quoin Pharmaceuticals Establishes Patient Specific Website For Ongoing Netherton Syndrome Clinical Study

Reuters · 09/13/2022 10:33
BRIEF-Quoin Pharmaceuticals Establishes Patient Specific Website For Ongoing Netherton Syndrome Clinical Study

- Quoin Pharmaceuticals Ltd QNRX.O:

  • QUOIN PHARMACEUTICALS ESTABLISHES PATIENT SPECIFIC WEBSITE FOR ONGOING NETHERTON SYNDROME CLINICAL STUDY

Source text for Eikon: ID:

Further company coverage: QNRX.O


((Reuters.Briefs@thomsonreuters.com;))